All > Alzheimer Disease > Alzheimers Disease

Citicoline supplement for Alzheimer's Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Emory University School of Nursing, Atlanta, GAAlzheimer's DiseaseCiticoline supplement - DietarySupplement
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a dietary supplement called citicoline will improve sleep and cognition in people with Alzheimer's disease. Citicoline has been shown to be well tolerated in previous studies.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
ALN-APP
1
ACU193
1
LY3372993

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: Baseline and 3 months

Baseline and 3 months
Change in the impact on daytime sleepiness by the addition of citicoline supplement to the standard of care treatment donepezil.
Change in the impact on sleep by the addition of citicoline supplement to the standard of care treatment donepezil.
To examine how a change in sleep correlates with changes in cognitive function with the addition of citicoline to the standard of care treatment donepezil.
To examine how a change in sleep correlates with changes in executive functioning with the addition of citicoline to the standard of care treatment donepezil.
To examine how a change in sleep correlates with changes in memory function with the addition of citicoline to the standard of care treatment donepezil.

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
ALN-APP
1
ACU193
1
LY3372993

Trial Design

2 Treatment Groups

Citicoline Supplement
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

20 Total Participants · 2 Treatment Groups

Primary Treatment: Citicoline supplement · Has Placebo Group · N/A

Citicoline Supplement
DietarySupplement
Experimental Group · 1 Intervention: Citicoline supplement · Intervention Types: DietarySupplement
Placebo
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Citicoline supplement
2018
N/A
~310

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and 3 months

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,527 Previous Clinical Trials
2,714,511 Total Patients Enrolled
Victoria Pak, PhD, MS, MTRPrincipal InvestigatorEmory School of Nursing, School of Public Health

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You give permission to be contacted in the future for other studies.
References

Frequently Asked Questions

How many participants has the research team recruited for this project?

"Affirmative. Clinicaltrials.gov indicates that this research trial, which was initially posted on July 27th 2022, is still actively seeking participants. The current goal is to enroll 20 individuals from two different medical facilities." - Anonymous Online Contributor

Unverified Answer

Are there any available spaces for participants in this research endeavor?

"Per the details available on clinicaltrials.gov, this research is currently enrolling participants and has been since its original posting date of July 27th 2022 - no updates have taken place in the interim." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top